Clinical Trials Directory

Trials / Completed

CompletedNCT03767608

Association Between Irisin, Inflammatory Markers and Metabolic Status in Obese Children With Type 2 Diabetes Mellitus

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Instituto Tecnologico y de Estudios Superiores de Monterey · Academic / Other
Sex
All
Age
6 Years – 17 Years
Healthy volunteers

Summary

The objective of this study was to investigate the association of irisin with inflammatory markers as well with metabolic and anthropometric parameters in children and adolescents with type 2 diabetes mellitus compared with healthy controls.

Detailed description

Mexican children and adolescents previously diagnosed with type 2 diabetes mellitus according to the American Diabetes Association (ADA) criteria were recruited and compared to healthy controls. The participants will undergo: * vital signs measurement (systolic and diastolic blood pressure, heart rate, respiratory rate) * anthropometric variables measurement (BMI, weight, waist circumference, hip circumference, body fat %) * laboratory studies: glucose, triglycerides, HDL-c, C reactive protein, irisin After statistical analyses the investigators will compare the relationship of irisin and the inflammatory profile and the anthropometric parameters of diabetic patients versus lean controls.

Conditions

Timeline

Start date
2016-01-01
Primary completion
2017-01-01
Completion
2017-01-01
First posted
2018-12-06
Last updated
2018-12-06

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT03767608. Inclusion in this directory is not an endorsement.

Association Between Irisin, Inflammatory Markers and Metabolic Status in Obese Children With Type 2 Diabetes Mellitus (NCT03767608) · Clinical Trials Directory